Analysis of drug lawsuits: an approach to the reality of the Federal District, Brazil

• Autor(a) principal: Cardoso, Cosme Santana
• Data de Publicação: 2017
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Cadernos Ibero-Americanos de Direito Sanitário (Online)
• DOI: 10.17566/ciads.v6i1.369
• Texto Completo: https://www.cadernos.prodisa.fiocruz.br/index.php/cadernos/article/view/369
• topic: Right to Health. Drugs. Lawsuits. Official Lists.; Derecho a la salud. Medicamentos. Proceso Judicial; Direito à saúde. Medicamentos. Ações judiciais

Introduction: The National Medicines Policy and the Pharmaceutical Assistance publications brought many advances and achievements in the field of medicines. Therefore advances in access to medicines in to SUS, there has been a lawsuit by increasing its supply. Objective: The objective of this study was to identify and quantify the drugs that were secured through litigation in TJDFT in 2011, and see if there was a decrease of the amount of standard drugs secured in court, registered in the system of judicial information from the Procuradoria Geral do Distrito Federal. Results: The research is classified as documentary, descriptive and retrospective data collection, expressed in a quali-quantitative way. Between 250 cases tabulated, 216 were used for this research. 100% of the cases analyzed refer to individual litigations, where 82.5% of the total were injunctions and coercive actions. Conclusion: Of the cases examined, it is noteworthy that 246 medicines were judicialized in DF in 2011. While the large majority of medicines requested was not included in any official list. Therefore, there is clearly a work of the local judiciary is not consistent with the public policy of the SUS.